Riskpilot← Back to searchSign inGet full accessMed&Motion Okkonen Oy
OYIn liquidationY-tunnus 2492551-8Makasiininkatu 4-B13Medical specialists activities · NACE 8622Est. 20120 employees
Revenue 2026
EUR 0
EBITDA margin
—
-100% vs 2025
Equity ratio
100.0%
Financial strength
Net profit 2026
EUR -44
-100% vs 2025
| Revenue | EUR 0 | — |
| EBITDA | EUR -44 | -100% |
| Net profit | EUR -44 | -100% |
| Total assets | EUR 11K | +0% |
| Equity | EUR 11K | +0% |
| Employees | 0 | — |
Legal name
Med&Motion Okkonen Oy
Y-tunnus number
2492551-8
Legal form
Osakeyhtiö
NACE code
8622 · Medical specialists activities
Founded
15. elokuuta 2012
Share capital
EUR 2 500
Employees
0
VAT registered
No
Audit selected
No
Last report
2026-02-06
Financial year
January – December
Signatory rights
Selvitystilan aikana selvitysmies yksin
Company purpose
Yhtiön toimialana on yksityislääkäritoiminnan harjoittaminen, erityisesti keuhkosairauksien erikois- sekä yleislääkäripalvelut, siihen liittyvät toimintakokeet, lääketutkimus ja seurantamittareiden kauppa. Lisäksi yhtiön toimialana on fyysinen valmennus ja testaustoiminta sekä ravitsemukseen liittyvä neuvonta. Edelleen yhtiö voi harjoittaa kaikkeen edellä kuvattuun toimintaan liittyvää koulutus- ja julkaisutoimintaa, henkilöstönvuokrausta sekä muuta laillista liiketoimintaa.
Address
Makasiininkatu 4-B13
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Revenue | 90 | — | 0 | 0 | 0 |
| Staff expenses | −27 | 37 | −42 | −9 | −0 |
| EBITDA | 44 | 50 | 30 | 23 | −0 |
| Depreciation & amort. | −2 | 6 | −5 | −3 | −0 |
| EBIT | 42 | 31 | 25 | 21 | −0 |
| Net financials | — | — | −29 | 0 | 0 |
| Profit before tax | 42 | 31 | −4 | 21 | −0 |
| Tax | 8 | 6 | 5 | −0 | −0 |
| Net profit | 33 | 25 | −9 | 21 | −0 |
| Item | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Total assets | 158 | 170 | 147 | 11 | 11 |
| Equity | 154 | 167 | 145 | 11 | 11 |
| Long-term debt | — | — | 0 | 0 | 0 |
| Short-term debt | 4 | 3 | 2 | 0 | 0 |
| Total debt | 4 | 3 | 2 | 0 | 0 |
EBITDA margin
-4400.0%
This company
15.8%
Market median
-27948% vs market
20222026
Equity ratio
100.0%
This company
38.2%
Market median
+162% vs market
20222026
Return on equity
-0.4%
This company
18.4%
Market median
-102% vs market
20222026
Net profit margin
-4400.0%
This company
8.1%
Market median
-54421% vs market
20222026
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20222026
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20222026
- Annual report 2026Filed via PRH / YTJ · Period 2026-01-01 – 2026-02-06
- Annual report 2025Filed via PRH / YTJ · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
HP Liquidator | Liquidator | 2025 |
| Former (3) | ||
TP Audit | Audit | 2012 – 2020 |
PA Chief Executive Officer | Chief Executive Officer | 2012 – 2025 |
OM Deputy Member | Deputy Member | 2018 – 2025 |
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
| Board of Directors | 2018 – 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Med&Motion Okkonen Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Timo Pekka Loikkanen | Audit | 0 companies |
| Pirjo Anneli Okkonen | Chief Executive Officer | 0 companies |
| Olli-Matti Mikael Okkonen | Deputy Member | 0 companies |
| Hanna Peppiina Lapinkangas | Liquidator | 0 companies |
| Ida Anne Maria Okkonen | Board of Directors | 0 companies |